Economic study of the value of expanding HCV treatment capacity in Germany

BACKGROUND: Today's highly efficacious, low-toxicity interferon-free treatment regimens for chronic hepatitis C virus (HCV) can cure most patients with HCV in 12–24 weeks. The aim of this study was to understand how the introduction of shorter duration treatment regimens for HCV will impact the...

Descripción completa

Detalles Bibliográficos
Autores principales: Sbarigia, Urbano, Wirth, Daniel, Van Nuys, Karen, Huber, Caroline, Brookmeyer, Ron, Stahmeyer, Jona, Krauth, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387957/
https://www.ncbi.nlm.nih.gov/pubmed/28461903
http://dx.doi.org/10.1136/bmjgast-2016-000130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387957/
https://www.ncbi.nlm.nih.gov/pubmed/28461903
http://dx.doi.org/10.1136/bmjgast-2016-000130

Ejemplares similares